BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34096639)

  • 1. Hidradenitis suppurativa with perifolliculitis capitis abscedens et suffodiens successfully treated with a human anti-tumour necrosis factor monoclonal antibody.
    Minakawa S; Matsuzaki Y; Rokunohe D; Kumagai N; Kurose A; Kushibiki M; Kayaba H; Sawamura D
    Clin Exp Dermatol; 2021 Dec; 46(8):1586-1588. PubMed ID: 34096639
    [No Abstract]   [Full Text] [Related]  

  • 2. Perifolliculitis Capitis Abscedens et Suffodiens Treated with Anti-tumor Necrosis Factor-alpha - Possible New Treatment Option.
    Sjerobabski Masnec I; Franceschi N
    Acta Dermatovenerol Croat; 2018 Oct; 26(3):255-289. PubMed ID: 30390728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases.
    Takahashi T; Yamasaki K; Terui H; Omori R; Tsuchiyama K; Fujimura T; Aiba S
    J Dermatol; 2019 Sep; 46(9):802-807. PubMed ID: 31271451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perifolliculitis capitis abscedens et suffodiens with hidradenitis suppurativa and nodulocystic acne treated with adalimumab.
    Kurokawa I
    J Dermatol; 2021 Aug; 48(8):e374-e375. PubMed ID: 33960498
    [No Abstract]   [Full Text] [Related]  

  • 5. Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin.
    Libow LF; Friar DA
    Cutis; 1999 Aug; 64(2):87-90. PubMed ID: 10467498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting cellulitis of the scalp treated by tumour necrosis factor inhibitors: a case series.
    Frechet L; Puzenat E; Charollais R; Dresco F; Carlet C; Gallais-Serezal I; Nardin C; Aubin F
    Eur J Dermatol; 2021 Feb; 31(1):81-85. PubMed ID: 33648906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Up-to-Date Approach to the Management of Dissecting Cellulitis.
    Nussbaum D; Desai S; Nelson K; Saardi K; Friedman A
    J Drugs Dermatol; 2022 Jul; 21(7):800-802. PubMed ID: 35816064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perifolliculitis capitis abscedens et suffodiens successfully treated with Saireito.
    Kurokawa I
    J Dermatol; 2019 Aug; 46(8):e299-e301. PubMed ID: 30809838
    [No Abstract]   [Full Text] [Related]  

  • 9. Photodynamic therapy combined with dermatosurgical approach for Perifolliculitis Capitis Abscedens et Suffodiens.
    Cui X; Zhu J; Yao X; Zhu W; Xu P; Wu X
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101767. PubMed ID: 32305655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinant factors of biological therapy for dissecting cellulitis of the scalp.
    Melgosa Ramos FJ; Berna-Rico E; Suarez-Valle A; Mateu Puchades A; Vañó-Galván S; García-Ruiz R; Saceda Corralo D
    J Dtsch Dermatol Ges; 2024 Jan; 22(1):115-117. PubMed ID: 38110849
    [No Abstract]   [Full Text] [Related]  

  • 11. Concurrent hidradenitis suppurativa, inflammatory acne, dissecting cellulitis of the scalp, and pyoderma gangrenosum in a 16-year-old boy.
    Koshelev MV; Garrison PA; Wright TS
    Pediatr Dermatol; 2014; 31(1):e20-1. PubMed ID: 24118007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting cellulitis of the scalp treated with tumour necrosis factor-α inhibitors: experience with two agents.
    Mansouri Y; Martin-Clavijo A; Newsome P; Kaur MR
    Br J Dermatol; 2016 Apr; 174(4):916-8. PubMed ID: 26527324
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissecting cellulitis (Perifolliculitis Capitis Abscedens et Suffodiens): a comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa.
    Scheinfeld N
    Dermatol Online J; 2014 May; 20(5):22692. PubMed ID: 24852785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perifolliculitis capitis abscedens et suffodiens successfully controlled with topical isotretinoin.
    Karpouzis A; Giatromanolaki A; Sivridis E; Kouskoukis C
    Eur J Dermatol; 2003; 13(2):192-5. PubMed ID: 12695138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab.
    Babalola F; Chima M; Jobarteh R; Gottlieb A
    J Drugs Dermatol; 2022 Mar; 21(3):313-314. PubMed ID: 35254754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy combined with carbon dioxide laser pretreatment for treatment of perifolliculitis capitis abscedens et suffodiens: A case report.
    Huang J; Wang H
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104064. PubMed ID: 38527661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial perifolliculitis capitis abscedens et suffodiens in two brothers successfully treated with isotretinoin.
    Bjellerup M; Wallengren J
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 1):752-3. PubMed ID: 2229506
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of pyoderma vegetans and the follicular occlusion triad.
    Boyd AS; Zemtsov A
    J Dermatol; 1992 Jan; 19(1):61-3. PubMed ID: 1534334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perifolliculitis capitis abscedens et suffodiens.
    PORTUGAL H; ANTUNES AG
    Rev Bras Med; 1951 Mar; 8(3):161-4. PubMed ID: 14844865
    [No Abstract]   [Full Text] [Related]  

  • 20. A short report on a case of Hoffman's perifolliculitis abscedens et suffodiens capitis. (Dissecting cellulitis of the scalp).
    KINGSLEY HJ
    Cent Afr J Med; 1962 May; 8():190. PubMed ID: 14456145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.